Clinical Trial Update: Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2) [Phase 2]

View source ↗

Summary

Phase 2 trial update for evogliptin in type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Evogliptin (evogliptin)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED